EpiHeart is conducting research with cardiac surgery units concerning the novel cardiac treatment Cardiac Micrograft Therapy™ . We thrive to provide the cardiac surgery units with the best possible equipment to create the best outcome for the patient. Your cardiac surgery unit (EU or US) can add its value by joining this pioneering multicenter study, and EpiHeart can provide you:
Learn more and join the research by contacting us.
EpiHeart's product portfolio enables secure delivery of tissue micrografts to the epicardium of the heart. In addition to this, the equipment offering creates safe foundation for future advanced cardiac treatments. If you have a need for surgical administration of cells or micrografts within your cell or gene therapy protocol, EpiHeart products enable you a direct route to the surface of the heart.
Contact us and tell us more about your needs.